88 related articles for article (PubMed ID: 23827153)
21. PEA3 activates CXCR4 transcription in MDA-MB-231 and MCF7 breast cancer cells.
Gu S; Chen L; Hong Q; Yan T; Zhuang Z; Wang Q; Jin W; Zhu H; Wu J
Acta Biochim Biophys Sin (Shanghai); 2011 Oct; 43(10):771-8. PubMed ID: 21831961
[TBL] [Abstract][Full Text] [Related]
22. [The effects of CXCR4 inhibited by RNA interference on metastasis and invasion of breast cancer cell in vitro].
Zhang SC; Qiao L; Gao H
Zhonghua Wai Ke Za Zhi; 2007 Apr; 45(7):473-5. PubMed ID: 17686306
[TBL] [Abstract][Full Text] [Related]
23. Silencing of bach1 gene by small interfering RNA-mediation regulates invasive and expression level of miR-203, miR-145, matrix metalloproteinase-9, and CXCR4 receptor in MDA-MB-468 breast cancer cells.
Mohammadzadeh R; Saeid Harouyan M; Ale Taha SM
Tumour Biol; 2017 Mar; 39(3):1010428317695925. PubMed ID: 28349828
[TBL] [Abstract][Full Text] [Related]
24. Role of RANK, RANKL, OPG, and CXCR4 tissue markers in predicting bone metastases in breast cancer patients.
Ibrahim T; Sacanna E; Gaudio M; Mercatali L; Scarpi E; Zoli W; Serra P; Ricci R; Serra L; Kang Y; Amadori D
Clin Breast Cancer; 2011 Dec; 11(6):369-75. PubMed ID: 21764390
[TBL] [Abstract][Full Text] [Related]
25. Downregulation of CXCR4 in Metastasized Breast Cancer Cells and Implication in Their Dormancy.
Nobutani K; Shimono Y; Mizutani K; Ueda Y; Suzuki T; Kitayama M; Minami A; Momose K; Miyawaki K; Akashi K; Azuma T; Takai Y
PLoS One; 2015; 10(6):e0130032. PubMed ID: 26083776
[TBL] [Abstract][Full Text] [Related]
26. Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma.
Kato M; Kitayama J; Kazama S; Nagawa H
Breast Cancer Res; 2003; 5(5):R144-50. PubMed ID: 12927045
[TBL] [Abstract][Full Text] [Related]
27. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells.
Kang H; Mansel RE; Jiang WG
Int J Oncol; 2005 May; 26(5):1429-34. PubMed ID: 15809737
[TBL] [Abstract][Full Text] [Related]
28. The role of CXCR4 in the prediction of bone metastases from breast cancer: a pilot study.
Sacanna E; Ibrahim T; Gaudio M; Mercatali L; Scarpi E; Zoli W; Serra P; Bravaccini S; Ricci R; Serra L; Amadori D
Oncology; 2011; 80(3-4):225-31. PubMed ID: 21734413
[TBL] [Abstract][Full Text] [Related]
29. TRAIL-R2 promotes skeletal metastasis in a breast cancer xenograft mouse model.
Fritsche H; Heilmann T; Tower RJ; Hauser C; von Au A; El-Sheikh D; Campbell GM; Alp G; Schewe D; Hübner S; Tiwari S; Kownatzki D; Boretius S; Adam D; Jonat W; Becker T; Glüer CC; Zöller M; Kalthoff H; Schem C; Trauzold A
Oncotarget; 2015 Apr; 6(11):9502-16. PubMed ID: 25909161
[TBL] [Abstract][Full Text] [Related]
30. The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study.
Salvucci O; Bouchard A; Baccarelli A; Deschênes J; Sauter G; Simon R; Bianchi R; Basik M
Breast Cancer Res Treat; 2006 Jun; 97(3):275-83. PubMed ID: 16344916
[TBL] [Abstract][Full Text] [Related]
31. Elevated chemokine receptor CXCR4 expression in primary tumors following neoadjuvant chemotherapy predicts poor outcomes for patients with locally advanced breast cancer (LABC).
Holm NT; Abreo F; Johnson LW; Li BD; Chu QD
Breast Cancer Res Treat; 2009 Jan; 113(2):293-9. PubMed ID: 18270814
[TBL] [Abstract][Full Text] [Related]
32. Blockade of invasion and metastasis of breast cancer cells via targeting CXCR4 with an artificial microRNA.
Liang Z; Wu H; Reddy S; Zhu A; Wang S; Blevins D; Yoon Y; Zhang Y; Shim H
Biochem Biophys Res Commun; 2007 Nov; 363(3):542-6. PubMed ID: 17889832
[TBL] [Abstract][Full Text] [Related]
33. A novel biphenyl urea derivate inhibits the invasion of breast cancer through the modulation of CXCR4.
Zhan Y; Zhang H; Li J; Zhang Y; Zhang J; He L
J Cell Mol Med; 2015 Jul; 19(7):1614-23. PubMed ID: 25753200
[TBL] [Abstract][Full Text] [Related]
34. Pomolic acid inhibits metastasis of HER2 overexpressing breast cancer cells through inactivation of the ERK pathway.
Kim B; Kim YC; Park B
Int J Oncol; 2016 Aug; 49(2):744-52. PubMed ID: 27277173
[TBL] [Abstract][Full Text] [Related]
35. Expression of CXCR4 is associated with axillary lymph node status in patients with early breast cancer.
Su YC; Wu MT; Huang CJ; Hou MF; Yang SF; Chai CY
Breast; 2006 Aug; 15(4):533-9. PubMed ID: 16239110
[TBL] [Abstract][Full Text] [Related]
36. Down-regulation of CXCR4 expression by tamoxifen is associated with DNA methyltransferase 3B up-regulation in MCF-7 breast cancer cells.
Kubarek Ł; Kozłowska A; Przybylski M; Lianeri M; Jagodzinski PP
Biomed Pharmacother; 2009 Sep; 63(8):586-91. PubMed ID: 19019622
[TBL] [Abstract][Full Text] [Related]
37. Baohuoside I suppresses invasion of cervical and breast cancer cells through the downregulation of CXCR4 chemokine receptor expression.
Kim B; Park B
Biochemistry; 2014 Dec; 53(48):7562-9. PubMed ID: 25407882
[TBL] [Abstract][Full Text] [Related]
38. Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis.
Darash-Yahana M; Pikarsky E; Abramovitch R; Zeira E; Pal B; Karplus R; Beider K; Avniel S; Kasem S; Galun E; Peled A
FASEB J; 2004 Aug; 18(11):1240-2. PubMed ID: 15180966
[TBL] [Abstract][Full Text] [Related]
39. Zerumbone down-regulates chemokine receptor CXCR4 expression leading to inhibition of CXCL12-induced invasion of breast and pancreatic tumor cells.
Sung B; Jhurani S; Ahn KS; Mastuo Y; Yi T; Guha S; Liu M; Aggarwal BB
Cancer Res; 2008 Nov; 68(21):8938-44. PubMed ID: 18974138
[TBL] [Abstract][Full Text] [Related]
40. First evidence supporting a potential role for the BMP/SMAD pathway in the progression of oestrogen receptor-positive breast cancer.
Helms MW; Packeisen J; August C; Schittek B; Boecker W; Brandt BH; Buerger H
J Pathol; 2005 Jul; 206(3):366-76. PubMed ID: 15892165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
